期刊文献+

儿童急性B淋巴细胞白血病CD4+CD25highFoxp3+调节性T细胞亚群改变及意义 被引量:4

Changes of CD4 +CD25highFoxp3 +regulatory T cells and their significance in childhood B-cell acute lymphocytic leukemia
原文传递
导出
摘要 目的:探讨急性B淋巴细胞白血病(B-ALL)患儿CD4+CD25highFoxp3+调节性T细胞( Treg)亚群改变及其在B-ALL免疫逃逸机制中的作用。方法急性期B-ALL患儿42例,正常同年龄对照组28例,分别于化疗前直接取血备检。采用流式细胞检测外周血CD4+CD25 high Foxp3+、CD4+CD25high ICOS+Foxp3+、CD4+CD25high ICOS-Foxp3+细胞比例及IL-10、TGF-β、IL-35、TGF-βRII、ICOS、CD28蛋白表达水平;荧光定量PCR ( real-time PCR)检测CD4+T细胞Smad3/4、TIEG1、Itch等mRNA表达;ELISA检测血浆中TGF-β浓度。结果(1)急性B-ALL患儿CD4+CD25high Foxp3+Treg细胞比例显著升高(P<0.05),其中ICOS+Foxp3+和ICOS-Foxp3+细胞比例均明显高于对照组(P<0.05), ICOS+Foxp3+/ICOS -Foxp3+比值低于对照组(0.73±0.21 vs 1.87±0.59,P<0.05);(2)急性期B-ALL患儿ICOS+Foxp3+细胞转录因子Foxp3及抑制性细胞因子IL-10、IL-35和TGF-β表达水平显著上调(P<0.05),ICOS-Foxp3+细胞Foxp3表达略有增加,但差异无统计学意义(P>0.05),其mTGF-β表达明显高于对照组( P<0.05);(3)急性B-ALL患儿血浆TGF-β浓度明显高于对照组[(25.83±12.65) ng/ml vs (8.59±5.73) ng/ml, P<0.05],CD4+T细胞表面TGF-βRII及下游信号分子Smad3/4、TIEG1、Itch表达水平显著上调(P<0.05),CD4+CD25highFoxp3+Treg细胞表面ICOS、CD28表达亦明显增高(P<0.05)。结论 TGF-β、ICOS、CD28信号过度活化可能是导致急性B-ALL患儿CD4+CD25highFoxp3+Treg细胞异常及其亚群比例失调的重要因素。 Objective To investigate the changes of CD4 +CD25highFoxp3 +regulatory T (Treg) cells and their significance in immune escape of childhood B-cell acute lymphocytic leukemia ( B-ALL ) . Methods Forty-two children with B-ALL and twenty-eight age-matched healthy children were enrolled in this study.Flow cytometry analysis was performed to evaluate the proportion of CD 4 +CD25high Foxp3 +Treg cells as well as CD4 +CD25high ICOS+Foxp3 +and CD4 +CD25high ICOS-Foxp3 +subsets in peripheral blood samples.The expression of associated molecules including IL-10, TGF-β, IL-35, TGF-βRII, ICOS and CD28 at protein level were also measured by flow cytometry analysis .The transcription level of Smad3/4, TIEG1 and Itch by CD4 +T cells were determined by quantitative real-time PCR.The concentration of TGF-βin plasma was detected by enzyme-linked immunosorbent assay.Results (1)The proportion of CD4 +CD25highFoxp3 +Treg cells in children with B-ALL were significantly higher than those of health subjects (P〈0.05).The proportion of both ICOS +Foxp3 +and ICOS -Foxp3 +subsets were increased in comparison with those of control group (P〈0.05), while the ratio of ICOS +Foxp3 +to ICOS-Foxp3 +was decreased (0.73 ±0.21 vs 1.87 ±0.59, P〈0.05).(2) The expression of Foxp3, TGF-β, IL-10 and IL-35 by ICOS+Foxp3 +Treg cells and the expression of membrane bound TGF-βby ICOS -Foxp3 +Treg cells were significantly increased in children with B-ALL (P〈0.05).However, the expression of Foxp3 by ICOS -Foxp3 +Treg cells showed no significant difference between the two groups (P〉0.05).(3)The concentra-tion of TGF-βin plasma from children with B-ALL were higher than those from control group [ ( 25 .83 ±12.65) ng/ml vs (8.59 ±5.73) ng/ml, P〈0.05].The expression of TGF-βRII and its associated mole-cules (Smad3/4, TIEG1 and Itch) by CD4 +T cells were significantly up-regulated.Moreover, an increased expression of ICOS and CD28 by CD4 +CD25highFoxp3 +Treg cells were also observed in children with B-ALL (P〈0.05).Conclusion The hyper-activity of TGF-β, ICOS and CD28 signaling might be closely associ-ated with the increased proportion of CD4 +CD25high Foxp3 +Treg cells and the imbalance of its subsets in children with B-ALL.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2014年第3期194-199,共6页 Chinese Journal of Microbiology and Immunology
基金 广东省自然科学基金(S201101000434) 深圳市医学重点学科建设基金资助
关键词 急性B淋巴细胞白血病 调节性T细胞 FOXP3 ICOS CD28 B-cell acute lymphoblastic leukemia Regulatory T cells Foxp3 ICOS CD28
  • 相关文献

参考文献16

  • 1Onciu M. Acute lymphoblastic leukemia[J]. Hematol Oncol Clin North Am, 2009, 23(4) : 655-674.
  • 2Oleinika K, Nibbs RJ, Graham GJ, et al. Suppression, subver- sion and escape: the rote of regulatory T cells in cancer progression [ J]. Clin Exp lmmunol, 2013, 171 ( 1 ) : 36-45.
  • 3Faeciabene A, Motz GT, Coukos G. T-regulatory cells: key play- ers in tumor immune escape and angiogenesis [ J ]. Cancer Res, 2012, 72(9) : 2162-2171.
  • 4Liu Y, Zhu T, Cai G, et al. Elevated circulating CIM+ ICOS+ Foxp3 + T cells contribute to overproduction of IL-10 and are corre- lated with disease severity in patients with systemic lupus erythe- matosus[ J]. Lupus, 2011 , 20(6) : 620-627.
  • 5Whitehead GS, Wilson RH, Nakano K, et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells rever- ses established IL-17-dependent allergic airways disease[ J]. J Al- lergy Clin hnmunol, 2012, 129( 1 ) : 207-15. e1-5.
  • 6Itn T, Hanabuchi S, Wang YH, et al. Two functional subsets of Foxp3+ regulatory. T cells in human thymus and periphery [ J ]. hnmunity, 2008, 28 (6): 870-880.
  • 7Faget J, Bendriss-Vermare N, Gobert M, et al. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive Cd4+ T cells[J]. Cancer Res, 2012, 72(23) : 6130-6141.
  • 8Martin-Orozco N, Li Y, Wang Y, et al. Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells[J]. Cancer Res, 2010, 70(23): 9581-9590.
  • 9Conrad C, Gregorio J, Wang YH, et al. Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS cos- timulation of Foxp3 ( + ) T-regulatory cells [ J ]. Cancer Res, 2012, 72(20) : 5240-5249.
  • 10Shenghui Z, Yixiang H, Jianho W, et al. Elevated frequencies of CD4 + CD25 + CD1271o regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia[J]. Int J Canc- er, 2011, 129(6) : 1373-1381.

同被引文献42

  • 1Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors (RECIST guidelines)[J]. J Natl Cancer Inst, 2009,92:205-216.
  • 2Knolle PA, Thimme R. Hepatic immune regulation and its involvement in viral hepatitis infection[J]. Gastroenterology,2014,146:1193-1207.
  • 3Williams SK, Donaldson E, Van der Kleij T, et al. Quantification of hepatic FOXP3 T-lymphocytes in HIV/hepatitis C coinfection[J]. J Viral Hepat,2014,21:251-259.
  • 4enner EK, Boguniewicz J, Tucker RM, et al. High-dose IgG therapy mitigates bile duct-targeted 7inflammation and obstruction in a mouse model ofbiliary atresia[J]. Pediatr Res,2014,76:72-80.
  • 5Billerbeck E, Labitt RN, Vega K, et al. Insufficient interleukin-12 signalling favours differentiation of human CD4+ and CD8+ T cells into GATA-3+ and GATA-3+ T-bet+ subsets in humanized mice[J]. Immunolog,2014,143:202 -218.
  • 6Vudattu NK, Waldron-Lynch F, Truman LA, et al. Humanized mice as a model for aberrant responses in human T cell immunotherapy[J]. J Immunol,2014,193:587-596.
  • 7Chen YF, Wang SH, Chang S J, et al. Zhankuic acidA as a novel JAK2 inhibitor for the treatment of concanavalin A-induced hepatitis[J]. Biochem Pharmacol,2014,91:217-230.
  • 8Oh da Y, Walenta E, Akiyama TE, et al. A Gprl20-selective agonist improves insulin resistance and chronic inflammation in obese mice[J]. Nat Med,2014,20:942-947.
  • 9Pan H,Feng DN,Song L,et al.Acute myeloid leukemiafollowing etoposide therapy for EBV-associated hemoph-agocytic lymphohistiocytosis:a case report and a brief re-view of the literature[J].BMC Pediatr,2016,16:116.
  • 10Pavlovic A,Glavina Durdov M,Capkun V,et al.Classicalhodgkin lymphoma with positive Epstein-Barr virus statusis associated with more FOXP3regulatory T cells[J].Med Sci Monit,2016,22:2340-2346.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部